- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Cassava Sciences is a biotechnology business based in the US. Cassava Sciences shares (SAVA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.89 – an increase of 15.6% over the previous week. Cassava Sciences employs 29 staff and has a market cap (total outstanding shares value) of 0.00.
What's in this guide?
Our top picks for where to buy Cassava Sciences stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
How to buy Cassava Sciences stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SAVA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Cassava Sciences stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Cassava Sciences stock price (NASDAQ: SAVA)
Use our graph to track the performance of SAVA stocks over time.Cassava Sciences shares at a glance
Latest market close | $2.89 |
---|---|
52-week range | $2.23 - $42.20 |
50-day moving average | $14.89 |
200-day moving average | $20.56 |
Wall St. target price | $116.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-1.38 |
Is it a good time to buy Cassava Sciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cassava Sciences price performance over time
Historical closes compared with the close of $2.75 from 2025-01-02
1 week (2024-12-27) | 10.00% |
---|---|
1 month (2024-12-04) | -6.78% |
3 months (2024-10-04) | -89.84% |
6 months (2024-07-03) | -74.47% |
1 year (2024-01-04) | -88.26% |
---|---|
2 years (2023-01-04) | -90.77% |
3 years (2022-01-04) | 48.19 |
5 years (2020-01-03) | 9.65 |
Cassava Sciences financials
Gross profit TTM | $-68,032,000 |
---|---|
Return on assets TTM | -45.6% |
Return on equity TTM | -10.98% |
Profit margin | 0% |
Book value | $3.47 |
Market Capitalization | $113.5 million |
TTM: trailing 12 months
Cassava Sciences share dividends
We're not expecting Cassava Sciences to pay a dividend over the next 12 months.
Have Cassava Sciences's shares ever split?
Cassava Sciences's shares were split on a 1:7 basis on 9 May 2017 . So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cassava Sciences shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Cassava Sciences shares which in turn could have impacted Cassava Sciences's share price.
Cassava Sciences share price volatility
Over the last 12 months, Cassava Sciences's shares have ranged in value from as little as $2.23 up to $42.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cassava Sciences's is -0.583. This would suggest that Cassava Sciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Cassava Sciences has bucked the trend.
Cassava Sciences overview
Cassava Sciences, Inc. , a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc.
Frequently asked questions
nullWhat percentage of Cassava Sciences is owned by insiders or institutions?
Currently 12.652% of Cassava Sciences shares are held by insiders and 29.931% by institutions. How many people work for Cassava Sciences?
Latest data suggests 29 work at Cassava Sciences. When does the fiscal year end for Cassava Sciences?
Cassava Sciences's fiscal year ends in December. Where is Cassava Sciences based?
Cassava Sciences's address is: 6801 N. Capital of Texas Highway, Austin, TX, United States, 78731 What is Cassava Sciences's ISIN number?
Cassava Sciences's international securities identification number is: US14817C1071 What is Cassava Sciences's CUSIP number?
Cassava Sciences's Committee on Uniform Securities Identification Procedures number is: 14817C107
More guides on Finder
-
Best Paper Trading Apps to Practice Trading With Fake Money in 2024
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
JP Morgan Personal Advisors Review
Access remote advice, planning and portfolio management from this established financial services company.
-
5 Best International Stock Brokers to Invest in Foreign Assets
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
-
9 Best Discount Brokers of 2024 for Low-Cost Trading
These are the best discount brokers of 2025 according to Finder’s comprehensive review.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
10 Best Stock Apps of 2024 to Elevate Your Mobile Trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
How to invest in the S&P 500 in 2025
What you need to know about investing in the leading indicator for the overall US stock market.
Ask a question